Harvard University Office of Technology Development Collaborative Research Opportunity Finder

1. James Rowlett, PhD

   Anxiety, addiction, cognition, and sleep: pharmacotherapy, GABA receptor

   Investigate the neuropharmacological basis of psychiatric disease and addiction, employing behavioral methodologies and translational approaches.  Primary areas of research include anxiety, ...

   

2. Roger Spealman, PhD

   CNS disorders: addiction; Parkinson’s disease

   Studies on the mechanisms and efficacy of psychoactive drugs  

   

3. Naoshige Uchida, PhD

   Neural basis of rapid olfactory decisions Reward-based decisions and learning

   Dr. Uchida’s laboratory studies how the brain recognizes and makes rapid decisions based on complex stimuli with remarkable speed and accuracy; uses the olfactory system as a model to ...

   

4. Wei-Dong Yao, PhD

   Dopamine signaling; synaptic plasticity; neurobiology of neuropsychiatric and neurodegenerative disorders

   

Research Categories

Central Nervous System

Disease Mechanisms

Sub-categories

1. Clinical Disorders and Disease Etiology

   1. Addiction»
   2. Age-related macular degeneration (AMD)»
   3. AIDS»
   4. Alzheimer’s disease»
   5. Amblyopia»
   6. Amyloid plaque»
   7. Amyloid precursor protein (APP)»
   8. Amyotrophic Lateral Sclerosis (ALS)»
   9. Atherosclerosis»
   10. Autism»
   11. Autoimmune disease»
   12. Bacterial infection»
   13. Behavioral disorders»
   14. Bench-to-bedside»
   15. Brain disease»
   16. Breast cancer»
   17. Cancer»
   18. Carcinoma»
   19. Cardiovascular disease»
   20. Cervical cancer»
   21. Chlamydia»
   22. Chronic viral infection»
   23. Circadian rhythm»
   24. Complex disease»
   25. Contact hypersensitivity»
   26. Cystic fibrosis lung infection»
   27. Cytomegalovirus»
   28. Cytoskeletal disease»
   29. Dementia»
   30. Dengue fever»
   31. Dengue hemorrhagic fever»
   32. Dengue Virus»
   33. Developing country»
   34. Diabetes»
   35. Disease genes»
   36. Disease prognosis»
   37. Down syndrome»
   38. Drug abuse»
   39. Ebola virus»
   40. Emerging infections»
   41. Epilepsy»
   42. Epithelial tumor»
   43. Filovirus»
   44. Flu»
   45. Glioblastoma»
   46. Hearing loss»
   47. Hepatitis»
   48. Hepatitis B»
   49. Hepatitis C»
   50. Hepatocellular carcinoma»
   51. Herpes simplex virus»
   52. HHV8»
   53. HIV»
   54. HPV»
   55. Huntington’s disease»
   56. Infectious disease»
   57. Inflammation»
   58. Influenza»
   59. Insomnia»
   60. Klinefelter’s syndrome»
   61. KSHV»
   62. Legionella»
   63. Lentivirus»
   64. Lentivirus infection»
   65. Leukemia»
   66. Liver cancer»
   67. Lymphoma»
   68. Malaria»
   69. Marburg virus»
   70. Membrane-enveloped viruses»
   71. Metabolic disease»
   72. Microorganism»
   73. Mitochondrial dysfunction»
   74. Mosquito-borne illness»
   75. Nervous system disorders»
   76. Neurodegeneration»
   77. Neurodegenerative disease»
   78. Neurological disease»
   79. Neurological disorders»
   80. Nondisjunction»
   81. Olfactory dysfunction»
   82. Opportunistic pathogen»
   83. Organ transplant rejection»
   84. Osteoporosis»
   85. Ovarian cancer»
   86. Parasites»
   87. Parkinson’s disease»
   88. Pathogen»
   89. Poliovirus»
   90. Post-traumatic stress disorder (PTSD)»
   91. Presenilin»
   92. Prostate cancer»
   93. Proteinopathy»
   94. Retinal degeneration»
   95. Retinal disorders»
   96. Retinal telangiectasia»
   97. Retinitis Pigmentosa»
   98. Salmonella»
   99. SARS»
   100. Schizophrenia»
   101. Side effects»
   102. SIV»
   103. SIV encephalitis»
   104. Spinal Muscular Atrophy (SMA)»
   105. Tropical disease»
   106. Turner syndrome»
   107. Vascular disease»
   108. Viral infection»
   109. Virus»
   110. Virus entry»
   111. X-linked mental retardation»

2. Psychological and Neurotransmitter Disorders

   1. Addiction»
   2. Anxiety»
   3. Benzodiazepine»
   4. Drug abuse»
   5. Extinction therapy»
   6. GABA»
   7. Sleep»